When you reconstitute a lyophilized peptide vial, the liquid you add isn't a neutral carrier. The choice between bacteriostatic water, sterile water, and saline decides whether the vial stays sterile for 28 days or has to be tossed after one dose. We'll show you which one to use and why.
Bacteriostatic water for injection (BWFI) is sterile water plus 0.9% benzyl alcohol, a mild preservative that gives you a 28-day in-use window in the fridge with no bacterial growth. Sterile water for injection (SWFI) has no preservative, so it is single-use only. Saline (0.9% NaCl) is a third option, and it clashes with some peptide classes. Choose wrong and you either dose from a vial growing bacteria or waste costly material.
Most peptide vials ship as a freeze-dried powder under vacuum or inert gas. To use the peptide, you have to add water back in. That step is reconstitution. The dried powder is stable for months at room temperature because there's no water for microbes or hydrolysis. The moment you add water, two clocks start ticking. The peptide begins slow chemical breakdown, and the vial becomes vulnerable to contamination every time you puncture the septum.
The standard fix for the contamination clock is BWFI. The benzyl alcohol inside it stops bacteria from replicating. This guide covers what that preservative actually does, when SWFI or saline is the better call, and the six steps that keep a reconstituted vial sterile for the full 28 days.
What does 0.9% benzyl alcohol actually do?
Benzyl alcohol is an aromatic alcohol (C₆H₅CH₂OH) that pharma has used as a preservative for decades. At 0.9% in BWFI, it produces a bacteriostatic environment. Bacteriostatic means bacteria that fall into the solution can't replicate. They aren't necessarily killed outright. That's the slower, gentler form of antimicrobial action.
The mechanism is membrane disruption. Benzyl alcohol slips into bacterial cell membranes and scrambles the membrane processes bacteria need to divide. Gram-negative bacteria, with their outer membranes, are hit hardest. Fungi (yeasts, molds) shrug it off more reliably. The 0.9% concentration is the dose that stops bacterial replication without irritating injection sites.
The pharmaceutical convention follows from that: a multi-dose vial reconstituted with BWFI is safe for 28 days when you keep it at 2–8°C, use sterile technique each time you draw, and inspect it before every dose. The same 28-day rule applies to human insulin, growth hormone, and most injectable peptide drugs.
Bacteriostatic water for injection is sterile water for injection containing 0.9% benzyl alcohol added as a bacteriostatic preservative. It is provided in multiple-dose containers from which multiple withdrawals may be made over a period not exceeding 28 days after first use.
— United States Pharmacopeia monograph for BWFI
What about sterile water for injection?
Sterile water for injection (SWFI) is the same product without the preservative. Pyrogen-free water in a sealed ampule. It's the cleanest possible diluent and works with every peptide class, including the rare ones that react with benzyl alcohol.
The cost is real, though. SWFI has no antimicrobial activity. The moment you open the ampule or reconstitute with it, you've started a sterile-window clock you can't extend. Standard pharmaceutical convention treats anything reconstituted with SWFI as single-use only. You toss any unused liquid after the first draw, no matter how much is left.
That's why SWFI is the wrong default for multi-dose peptide work. Use it only when you're reconstituting a one-shot volume, or when the specific peptide has a documented benzyl alcohol incompatibility (rare in research peptides; more common in certain growth-hormone preparations). For everything else, BWFI saves you 27 days of vial life.
What about saline (0.9% sodium chloride)?
Normal saline is the third option you'll see. Saline is isotonic, meaning it matches the osmotic pressure of body fluids, which can make injections feel less stingy than hypotonic alternatives. Some clinical protocols prefer it for that reason.
The compatibility catch is real. Some peptides aggregate, change shape, or break down faster in high-salt solutions. Others are perfectly fine in saline. The pragmatic call: BWFI handles a wider range of research peptides as a universal default. Reach for saline only when the specific peptide's documentation says to.
One more wrinkle. Most saline ampules are preservative-free, which means the same single-use limit applies as with SWFI. Preserved saline exists but rarely shows up outside specific clinical settings.
The diluent decision, in one block: Use BWFI (0.9% benzyl alcohol) for any multi-dose vial. Stored at 2–8°C, you get a 28-day in-use window. Use SWFI only when you're dosing once and tossing the rest, or when a specific peptide has documented benzyl alcohol incompatibility. Use saline only when the peptide's own documentation calls for it. BWFI is the default; the other two are exceptions.
Bacteriostatic Water
ReconstitutionThe standard 0.9% benzyl alcohol diluent for reconstituting lyophilized peptide vials. The same reference preparation used across the protocols in this guide.
What does the reconstitution procedure look like?
This is the mechanics, not a dosing guide. The concentration you target depends on your specific peptide and protocol.
You'll need: the lyophilized peptide vial, a vial of BWFI (or your chosen diluent), a sterile syringe sized for the transfer, alcohol swabs, and a fridge for storage. Sterile technique throughout matters more than any single step below.
- Warm cold vials to room temperature. Cold vials draw condensation, which complicates the transfer. Inspect both vials for damage, particulates, or weird colors before going further.
- Swab both septa with 70% isopropyl alcohol and let dry. The septum (the rubber stopper) is where contamination enters. Don't shortcut this.
- Draw your diluent from the BWFI vial into the sterile syringe at the volume your protocol calls for.
- Inject the diluent down the inside wall of the peptide vial, not straight onto the powder. A forceful blast onto the lyophilized cake foams the solution and can denature the peptide. Slow, down-the-wall delivery minimizes shear stress.
- Swirl gently. Roll the vial between your palms; don't shake. Most peptides dissolve in 30 seconds to a few minutes at room temperature.
- Check for clarity. A good reconstitution looks clear with no particulates. Cloudiness, floating bits, or stubborn foam means something went wrong: incomplete dissolution, an incompatible diluent, or a stability problem in the powder.
- Label the vial with the reconstitution date and final concentration. Your 28-day clock starts the moment you added water, not the day you opened the BWFI.
- Store at 2–8°C between uses. Most lyophilized peptides tolerate one freeze-thaw cycle if you absolutely need it. Repeated freeze-thaw cycles damage anything with structural complexity.
Two cautions worth flagging. First, peptides are biologically active. Don't reuse syringes or needles across different peptides without cleaning or replacement; cross-contamination is a real risk. Second, the cake itself should look intact, dry, and uniformly colored. A collapsed, melted, or discolored cake means heat exposure or moisture got in. Don't use it.
Does benzyl alcohol damage peptides?
For most research peptides, no. The 0.9% concentration in BWFI is chemically compatible with the vast majority of compounds you'll work with, and you'll see no measurable degradation over the 28-day window.
The exceptions are specific. Certain interferons, some growth-factor proteins, and a handful of larger protein therapeutics react with benzyl alcohol. The mechanism is either direct chemistry (benzyl alcohol interacting with reactive amino-acid side chains) or membrane-effect denaturation in structurally complex proteins. The small, simple peptides that dominate research catalogs aren't affected by this. The larger biologics are.
One safety signal is worth knowing about even though it's outside the research-peptide use case. Benzyl alcohol has caused toxicity in premature infants — the "gasping syndrome" — at high cumulative exposures. BWFI is contraindicated in neonates and infants. This is population-specific, not a general red flag, but it's the one well-documented adverse event linked to BWFI.
What's the typical vial size and storage?
The standard pharmaceutical preparation is a 30 mL multi-dose vial of BWFI, USP. That size handles multiple peptide reconstitutions over a working period. 10 mL and 50 mL preparations exist for niche cases.
Unopened BWFI vials are stable at room temperature for years. No fridge needed before the first puncture. After you puncture the septum, the same 28-day convention applies and you store the vial at 2–8°C between uses. Glance at the liquid before every reconstitution: clear, colorless, no particulates. The preservative reduces contamination risk dramatically, but a quick visual check is still cheap insurance.
Bacteriostatic Water
ReconstitutionUSP-grade bacteriostatic water for injection · 30 mL multi-dose vial. The standard diluent for reconstituting lyophilized peptide vials over a 28-day in-use window.
Where this falls short: The 28-day window is a pharmaceutical baseline, not a peptide-specific stability claim. Specific compounds may degrade faster (heat-sensitive peptides, certain glycoproteins) or last longer with proper handling. Manufacturer stability data overrides the general rule. And BWFI says nothing about whether your peptide identity or purity matches the COA; that's a separate testing chain. The preservative protects against microbial growth; it doesn't protect against bad starting material.
What questions should I bring to a clinician?
If you have access to clinical guidance, these are the diluent questions worth raising:
- Are there documented benzyl alcohol incompatibilities for this specific peptide? Most research peptides are fine, but it's worth asking.
- What reconstitution volume hits my target concentration? That's peptide-specific and protocol-specific math.
- What's the actual in-use stability window for this peptide? The 28-day rule is a baseline. Manufacturer data is authoritative.
- What does proper sterile technique look like in my workspace? Alcohol-swab discipline, single-use needles, and refrigerated storage all decide the real sterility window.
- What are the discard signs? Cloudiness, visible particulates, discoloration, persistent foam, or any odd odor means you toss the vial.
What to know now
- BWFI: sterile water + 0.9% benzyl alcohol. The default diluent for multi-dose vials.
- In-use window: 28 days at 2–8°C after reconstitution. USP standard.
- SWFI: no preservative, single-use only. Use when documented benzyl alcohol incompatibility exists.
- Saline (0.9% NaCl): specialized; compatibility varies by peptide class. Not a universal substitute.
- Technique: swab the septum, inject slowly down the inside wall, swirl gently (don't shake), inspect for clarity.
- Storage: 2–8°C between uses. Let it warm to room temp before each draw.
- Discard if: cloudy, particulates, discoloration, persistent foam, or any sign of contamination.
- Neonatal caution: benzyl alcohol is contraindicated in neonates and infants. Not relevant to adult research, but worth knowing.
What we're watching
Two things. First, the pharma shift toward single-dose prefilled syringes for specialty injectables. They sidestep the benzyl alcohol compatibility and population-restriction issues at the cost of every-dose disposables. Second, peptide-specific stability data from manufacturers. The 28-day rule is a baseline; individual peptides may need shorter windows in practice, and that data should drive your actual storage decisions.
References
- United States Pharmacopeia. Bacteriostatic Water for Injection, USP. Monograph in current USP-NF. https://www.usp.org/usp-nf
- American Society of Health-System Pharmacists (ASHP). Handbook on Injectable Drugs: Benzyl alcohol preservative compatibility and stability data. https://www.ashp.org/products-and-services/database-tools/handbook-on-injectable-drugs
- Trissel, L. A. Handbook on Injectable Drugs (current edition). Bethesda, MD: ASHP. https://www.ashp.org/products-and-services/database-tools/handbook-on-injectable-drugs
